Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'pi3 kinase p110'

Search results for: 'pi3 kinase p110'

Items 181-190 of 195

Page
per page
  1. GSK690693
    A5072 GSK690693
    Target: Akt|PKC|PKG|PKA|Prk
    Summary: Pan-AKT inhibitor,ATP-competitive and potent
      ≥21.25 mg/mL
  2. OSU-03012 (AR-12)
    A2846 OSU-03012 (AR-12)
     1 Citation
    Target: PDK-1
    Summary: Potent PDK1 inhibitor
      ≥23 mg/mL
  3. Dovitinib (TKI-258, CHIR-258)
    A2168 Dovitinib (TKI-258, CHIR-258)
     2 Citation
    Target: FLT3|VEGFR|PDGFR|c-Kit|FGFR
    Summary: Multitargeted RTK inhibitor
      insoluble in H2O; insoluble in EtOH; ≥36.35 mg/mL
  4. Dovitinib (TKI258) Lactate
    B5953 Dovitinib (TKI258) Lactate
    Target: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFR
    Summary: Oral tyrosine kinase inhibitor (TKI) against FGFR1–3, VEGFR1–3, and platelet-derived growth factor receptor (PDGFR).
      insoluble in EtOH; ≥10.62 mg/mL
  5. LY 294002
    A8250 LY 294002
     16 Citation
    Target: PI3K
    Summary: Potent PI3K inhibitor
  6. BS-181
    A3266 BS-181
    Target: Cyclin-Dependent Kinases
    Summary: CDK7 inhibitor,highly selective
      Soluble in DMSO
  7. Plumbagin
    A4456 Plumbagin
    Summary: Anticancer agent
  8. Axitinib (AG 013736)
    A8370 Axitinib (AG 013736)
     1 Citation
    Target: VEGFR|PDGFR|c-Kit
    Summary: VEGFR1/ c-Kit inhibitor
      insoluble in H2O; ≥19.3 mg/mL
  9. Dabrafenib Mesylate (GSK-2118436)
    A3347 Dabrafenib Mesylate (GSK-2118436)
    Target: Raf
    Summary: Inhibitor of BRAF(V600) mutants
      ≥30.75 mg/mL
  10. Flavopiridol
    A3417 Flavopiridol
    Target: Cyclin-Dependent Kinases
    Summary: Pan-cdk inhibitor
      insoluble in H2O; ≥40.2 mg/mL

Items 181-190 of 195

Page
per page
Shop By
Now Shopping by
  1. Related Disease Cancer Remove This Item
Clear All
Shopping Options
Specificity
  1. Selective 153item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 18item
  2. Irreversible 6item
Target
  1. Cyclin-Dependent Kinases 22item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 4item
  4. PI3K 11item
  5. Raf 9item
  6. Aurora Kinases 16item
  7. CSF-1R 4item
  8. mTOR 5item
  9. FLT3 7item
  10. GSK-3 4item
  11. PLK 5item
  12. Chk 4item
  13. Eph Receptors 3item
  14. VEGFR 27item
  15. PDGFR 17item
  16. c-Kit 9item
  17. RET 4item
  18. Bromodomain-containing proteins(BRDs) 1 item
  19. p38 3item
  20. JNK 1 item
  21. SGK 2item
  22. Bcr-Abl 6item
  23. MEK 2item
  24. FGFR 9item
  25. Pim 3item
  26. Ribosomal s6 kinases (RSK) 1 item
  27. MET 5item
  28. Src 8item
  29. Trk Receptors 1 item
  30. STAT 1 item
  31. EGFR 13item
  32. PAK 3item
  33. FAK 4item
  34. BMP and Other Activin Receptors 1 item
  35. JAK 7item
  36. Syk 3item
  37. DNA-PK 4item
  38. ErbB 4item
  39. ERK 2item
  40. c-MET 5item
  41. PKC 8item
  42. Ubiquitin-specific proteases 1 item
  43. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  44. Lyn 1 item
  45. HER2 1 item
  46. Pyk2 3item
  47. Insulin and Insulin-like Receptors 2item
  48. ALK 5item
  49. ROS1 1 item
  50. Sphingosine kinases (SphKs) 1 item
  51. PKG 2item
  52. PKA 4item
  53. Myosin light chain kinases (MLCKs) 1 item
  54. MELK 1 item
  55. Insulin-like growth factors (IGFs) 1 item
  56. MK2 1 item
  57. Tie-2 1 item
  58. RSK 1 item
  59. ATM/ATR 3item
  60. CK1 1 item
  61. Farnesyl Diphosphate Synthases 1 item
  62. CK2 1 item
  63. HIPK2 1 item
  64. HIPK3 1 item
  65. P110 1 item
  66. Hck 1 item
  67. MNK 1 item
  68. Insulin Receptors 1 item
  69. IRG-1R 1 item
  70. eEF-2 1 item
  71. Cdc7 1 item
  72. ZAP-70 1 item
  73. c-RET 2item
  74. p70 rsk 1 item
  75. VEGFR3/FLT4 1 item
  76. NTRK1/TRKA 1 item
  77. CSF-1R/c-Fms 1 item
  78. TAM kinase 1 item
  79. KDR 1 item
  80. AXL 1 item
  81. insulin 1 item
  82. ErbB-2 1 item
  83. PDK-1 1 item
  84. Prk 1 item
  85. Flk1 2item
  86. tropomyosin receptor kinase 1 item
  87. SK 1 item
  88. PPK 1 item
  89. c-Syk 1 item
  90. CDK1/CyclinB 1 item
  91. PIM1 kinase 1 item
  92. phospholipase A2 1 item
Reported Experiments
  1. Animal Experiments 182item
  2. Cell Experiments 120item